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INTRODUCTION
The ‘hygiene hypothesis’ states that advancing hygiene
eliminates environmental cues, such as infections, that skew
adaptive immunity away from Th2 responses and causes a
striking increase in allergic diseases including asthma (1).
In this context, many animal studies have shown that bacille
Calmette-Guerin (BCG) and other mycobacterial agents sup-
press Th2-associated allergy and asthma, probably through
Th1 (2-5) or regulatory T cell (6) immune responses. In
addition, we previously demonstrated that BCG vaccina-
tion improves lung function and reduces medication use in
adult patients with asthma (7), while other investigators
failed to show any beneficial effect (8, 9) or showed only a
limited effect (10). This discrepancy in the effects of BCG
vaccination maybe related to the factors affecting the effica-
cy including timing of vaccination, the route of delivery,
genetics and ethnicity, exposure to environmental mycobac-
teria (11), and BCG strain (12). 
The interaction of BCG and toll-like receptor (TLR) 2 on
dendritic cells (DCs) may affect the differentiation of naive
T cells mainly to Th1-like cells with the help of interleukin
(IL)-10, IL-12, and so forth (11). However, in addition to
the above controversies on the therapeutic effect of BCG in
patients with asthma, De Wit et al. (13) showed that when
DCs from atopic patients were pulsed beforehand with an
allergen, IL-12 could not inhibit IL-5 production by T cells.
Because co-administration of ovalbumin with IL-18 (14) or
CpG motifs (15) effectively suppresses production of Th2
cytokines, we can speculate that simultaneous administra-
tion of BCG with an allergen may suppress Th2 responses
even though BCG alone is not so much effective in estab-
lished allergic diseases. 
To support our previous report (7) shown beneficial effects
of BCG on human asthma and to elucidate the underling
mechanism for the effects, we observed the responses to BCG
of DCs and T cells from asthma patients sensitized to Der-
matophagoides farinae (D. farinae) with exposing both aller-
gen and BCG simultaneously in this study.
MATERIALS AND METHODS
Subjects
A study that examined the relationship between dyspnea
perception and airway hyper-responsiveness to methacholine
in asthma was conducted at Chonnam National University
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BCG-Induced Dendritic Cell Responses and Suppression of 
Interleukin-5 Production from T Cells in Atopic Asthmatics
Bacille Calmette-Guerin (BCG) induces potent Th1 responses with the help of inter-
leukin (IL)-10 and IL-12 released from dendritic cells (DCs), and suppresses Th2-
associated allergic reactions. However, there are still some controversies on thera-
peutic effects of BCG in asthmatics. This study investigated whether BCG admin-
istration to DCs suppresses IL-5 production from T cells in atopic asthmatics. DCs
derived from peripheral blood of subjects were cultured with or without BCG and
Dermatophagoides farinae extract. Some DCs were co-cultured with T cells in the
presence of BCG or the above culture supernatants. In the atopic asthmatics, BCG
significantly increased IL-10 and IL-12 production from DCs. In the presence of D.
farinae extract, BCG further increased IL-10 production. BCG-induced IL-10 pro-
duction was significantly higher in the atopics (n=14) than in the non-atopics (n=9).
Both BCG and the BCG-treated DCs culture supernatant significantly increased
IFN-γ production from T cells. Both BCG and the supernatant from DCs+BCG+D.
farinae co-cultures significantly decreased IL-5 production (all p<0.05), but the super-
natant from DCs+BCG co-cultures did not. In conclusion, administration of BCG
together with D. farinae extract effectively decreased IL-5 production from T cells,
probably through the action of IL-10 and IL-12 released from DCs in D. farinae-
sensitive asthmatics. 
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Hospital, Gwangju, Korea, between October and Decem-
ber 2005. The study enrolled medical students, hospital
employees including doctors and nurses, and patients who
required a medical certificate for asthma in order to be exempt-
ed from obligatory military service, mostly young adult men.
Forty of the 63 adult volunteers who participated in that
study donated their blood (50 mL) for the present study.
However, two of them did not meet the criteria for group
classification in this study, and appropriate numbers of DCs
were harvested from the blood samples of 23 of the remain-
ing 38 volunteers. The data from the 23 subjects were used
for the statistical analysis, and clinical characteristics of sub-
jects are presented in Table 1. 
The group criteria were as follows: non-atopic normal
group, healthy subjects who were not sensitized to ten com-
mon aeroallergens; atopic normal group, healthy subjects
sensitized to D. farinae; non-atopic asthma group, asthma
patients who were not sensitized to ten common aeroaller-
gens; and atopic asthma group, asthma patients sensitized
to D. farinae. Before the study, all of the subjects withheld
their medications for asthma or allergy for one week and
bronchodilators for 12 hr. The Institutional Review Board
of Chonnam National University Hospital approved this
study. All of the subjects were informed of the experimental
procedures, and all provided written informed consent. 
Study design
On the study day, allergy skin-prick tests and methacholine
bronchoprovocation test were performed after taking a his-
tory and conducting a physical examination. Then, if the
above criteria were met, laboratory tests for complete blood
counts and serum total IgE and blood sampling for periph-
eral blood mononuclear cell culture were performed. DCs
were isolated from the blood cells and cultured with or with-
out BCG and D. farinae extract. Some DCs were co-cultured
with T cells in the presence of BCG or the above culture
supernatants, and T cell proliferation and cytokine levels
were measured.
Clinical studies 
Allergy skin-prick tests were conducted using ten com-
mon aeroallergen extracts (Allergopharma, Reinbek, Ger-
many): D. farinae, Dermatophagoides pteronyssinus, cockroach,
cat, dog, Aspergillus, hazel, birch, timothy, and ragweed. His-
tamine (1 mg/mL) and saline (0.9%) solutions were used as
the positive and negative controls, respectively. Skin test
reactivity was graded according to the ratio of the size of the
allergen-induced wheal to the size of the wheal elicited by
the histamine solution, and was categorized as follows: 1+:
25-49%, 2+: 50-99%, 3+: 100-199%, 4+: ≥200%. The
sum of the grades for the ten allergens was defined as ‘atopy
score’, and the reactivity of ≥3+ or <1+ was regarded as
indicating clinically significant positive or negative responses,
respectively. The bronchial challenge tests followed a stan-
dardized tidal breathing method (16). A positive test response
was defined as a 20% fall in the forced expiratory volume in
1 sec in response to a provocation concentration of metha-
choline of <16 mg/mL. Asthma was defined as asthma symp-
toms and a positive bronchial challenge response.
Generation of DCs and T cells
Dendritic cells were generated from peripheral blood
mononuclear cells (PBMCs), as described by Romani et al.
(17). Briefly, PBMCs from the volunteers were isolated by
density gradient centrifugation using Lymphoprep (Nycom-
ed, Oslo, Norway). The CD14+ cells were isolated from the
PBMCs using an LS-MACS column (Miltenyi Biotec, Auburn,
CA, U.S.A.), in which the purity of the CD14+ cells exceed-
ed 95%. DCs were generated by culturing the CD14+ cells
(1×106/mL) with 50 ng/mL GM-CSF (LG Biochemical,
Daejeon, Korea) and 50 ng/mL IL-4 (R & D Systems, Min-
neapolis, MN, U.S.A.) for 6 days in T-25 culture flasks (Nunc,
Roskilde, Denmark) containing RPMI 1640 (BioWhittak-
er, Walkersville, MD, U.S.A.) supplemented with 10% fetal
bovine serum (Gibco, Grand Island, NY, U.S.A.), 100 U/mL
penicillin, 100 μ g/mL streptomycin, and 0.25 μ g/mL ampho-
tericin B (BioWhittaker). CD3+ T cells were isolated using
human T cell enrichment columns (R & D Systems), in which
the purity of the CD3+ cells exceeded 90%, and the T cells
were stored in liquid nitrogen until culture.
BCG and D. farinae treatment of DCs
Live attenuated BCG (Tokyo 172 strain; Korean National
Tuberculosis Association, Seoul) was cultured for 3 weeks in
a semisolid mixture of Middlebrook 7H10 agar (Becton Dick-
inson, Sparks, MD, U.S.A.) and Middlebrook 7H9 broth
Non-atopic
normal
(n=4)
Atopic
normal
(n=6)
Non-atopic
asthma
(n=5)
Atopic
asthma
(n=8)
Age (yr) 29.0±2.3 24.0±0.4 26.0±2.2 26.6±1.2
Sex (men/women) 4/0 5/1 2/3 7/1
Blood eosinophils (/μ L)* 102±15 349±73 116±48 319±80
Serum total IgE  44 136 35 212
(Geometricmean, IU/mL)*
Atopy score
� 0 10.0±0.7 0 10.5±2.0
FEV1 (% predicted) 92.0±2.0 93.3±5.8 83.6±3.3 91.0±6.1
PC20 (Geometric mean, >16 >16 5.77 3.52
mg/mL)
Table 1. Characteristics of subjects 
*p<0.05 and 
� p<0.001: Kruskal-Wallis test; FEV1, forced expiratory vol-
ume in one second; PC20, provocation concentration resulting in a 20%
fall in FEV1.630 I.S. Choi, X.-H. Lin, Y.-A. Koh, et al.
(Becton Dickinson) supplemented with 10% Middlebrook
oleic acid-albumin-dextrose catalase (Becton Dickinson). The
colonies were counted before preparing the inoculum. DCs
(1×105/mL) were cultured with 1.5×105 colony-forming
units (CFUs) of BCG with or without D. farinae extract
(group 1 allergen, 10 μ g/mL; Allergy Research Institute of
Yonsei University, Seoul) for 24 hr. The culture supernatants
were used for IL-10 and IL-12 assays or were added to the
DC-T cell co-cultures described below. 
DC-T cell cocultures
CD3+ T cells were thawed on the day of use. T cells (1×
105/mL) were co-cultured with irradiated (30 Gy) autolo-
gous DCs at a 10:1 ratio for 4 days. BCG (1.5×105 CFUs)
or the culture supernatants from BCG-treated DCs (100 μ L/
well) together with D. farinae extract were added at the begin-
ning of the DC-T cell co-culture. The supernatants were col-
lected from the cultures on day 3 and stored at -70℃ for
cytokine assays of IFN-γand IL-5.
T cell proliferation and cytokine determinations
T cell proliferation during the last 18 hr of 4-day cultures
was quantified using [3H] thymidine uptake of cells incubat-
ed with 1 μ Ci of [methyl-3H]-thymidine (Amersham Phar-
macia Biotech, Buckinghamshire, U.K.). The cells were har-
vested onto paper filters using a Titertek Cell Harvester 530
(Flow Laboratories, Irvine, U.K.), and the radioactivity was
measured using a Beckman LS 6500 multipurpose scintilla-
tion counter (Beckman Instruments, Fullerton, CA, U.S.A.).
The results are presented as the mean counts per minute
(cpm) of triplicated cultures. The concentrations of IL-5, IL-
10, IL-12, and IFN-γin the culture supernatants were deter-
mined using commercial enzyme-linked immunosorbent
assay (ELISA) kits (BioSource, Nivelles, Belgium). The sen-
sitivities of the assays for IL-5, IL-10, IL-12, and IFN-γwere
4, 1, 2, and 4 pg/mL, respectively. 
Statistical analysis
The data were expressed as the mean±SEM. To deter-
mine the significance of inter-group and intra-group differ-
ences, the chi-square test, Kruskal-Wallis test, Mann-Whit-
ney U test and Wilcoxon’s signed-rank test were used. A
value of p<0.05 was considered statistically significant. 
RESULTS
IL-10 and IL-12 productions by DCs
In the atopic asthma group, BCG treatment significantly
increased IL-10 and IL-12 productions by DCs. In the pres-
ence of D. farinae extract, BCG further increased the pro-
duction of IL-10 but not IL-12 (Fig. 1). The other study
groups also showed a similar trend (Table 2). In addition,
the IL-10 level in the culture supernatants of DCs+BCG
with (p<0.01) or without (p<0.05) D. farinae were signifi-
cantly higher in the atopic asthma group (n=8) than in the
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Fig. 1. Interleukin (IL)-10 and IL-12 concentrations in the supernatant of dendritic cell (DC) culture with or without BCG and Dermatopha-
goides farinae (Df) extract in the atopic asthmatics (n=8). 
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IL-10 (pg/mL)
DCs 3±21 ±11 ±11 ±0
DCs+BCG 39±15* 119±32 33±24* 108±16
DCs+BCG+Df 188±65
� 377±108 131±63
� 437±34
IL-12 (pg/mL)
DCs 624±134* 296±148 456±136 265±42
DCs+BCG 839±10 857±8 871±9 857±6
DCs+BCG+Df 860±8 852±7 843±10 855±8
Table 2. Comparisons of Interleukin (IL)-10 and IL-12 concentra-
tions in the culture supernatants of dendritic cells (DCs) among
study groups
Df, Dermatophagoides farinae extract; BCG, Bacille Calmette-Guerin.
*p<0.05 and 
�
p<0.01 compared to atopic asthma.BCG-Induced DC Responses and IL-5 Suppression 631
non-atopic asthma group (n=5) and than in the non-atopic
normal group (n=4, p<0.05). The atopic normal group show-
ed a similar trend with the atopic asthma group, and so BCG-
induced IL-10 productions were significantly higher in the
atopics (n=14) than in the non-atopics (n=9) (all p<0.01).
The baseline IL-12 level was significantly lower in the atopic
asthma group than in the non-atopic normal group (p<0.05).
The atopic normal group showed a similar trend with the
atopic asthma group, and so the baseline IL-12 level was
significantly lower in the atopics than in the non-atopics
(p<0.05).
T cell proliferation and IFN-γ γand IL-5 productions by T
cells
In the atopic asthma group, BCG treatment significantly
increased T cell proliferation (Fig. 2). And the D. farinae
extract alone increased T cell proliferation. However, the
addition of the culture supernatants from DCs+BCG co-
cultures resulted in a significantly lower proliferation index
(3H-thymidine incorporation) than BCG did. The other
study groups also showed a similar trend without statistical
significance.
Similarly, IFN-γproduction was increased significantly
with BCG treatment in the atopic asthma group (Fig. 3).
BCG tended to further increase IFN-γproduction in the pres-
ence of D. farinae extract (p=0.13). The supernatants from
DCs+BCG co-cultures also significantly increased IFN-γ
production. However, as compared with BCG, the super-
natant from DCs+BCG cultured in the absence of D. fari-
nae extract resulted in significantly lower IFN-γproduction
(p<0.05). Similar trends were observed for the other study
groups without statistical significance (Table 3). In addition,
the IFN-γlevels were significantly lower in the non-atopic
asthma group (n=4) in the most comparisons as compared
with the non-atopic normal group (n=4). The atopic asth-
ma group showed a similar trend with the non-atopic asth-
ma group, and the baseline and BCG+D. farinae IFN-γlev-
els were significantly lower in the asthmatics than in the
non-asthmatics (all p<0.05).
In the atopic asthma group, D. farinae extract significantly
Fig. 2. T cell proliferation in the supernatant of co-cultures of den-
dritic cells and T cells from the atopic asthmatics (n=8) with or
without BCG, Dermatophagoides farinae (Df) extract and super-
natant of dendritic cells-BCG co-culture. Sup1, supernatant of
dendritic cells and BCG co-culture; Sup2, supernatant of den-
dritic cells, BCG, and Df co-culture. 
T
 
c
e
l
l
 
p
r
o
l
i
f
e
r
a
t
i
o
n
 
(
c
p
m
)
12,000
10,000
8,000
6,000
4,000
2,000
0
(-) +Df
+BCG
+Df+BCG
+Df+Sup1
+Df+Sup2
p<0.05 p<0.05
p<0.05 p<0.05
Fig. 3. Interferon (IFN)-γ concentration in the supernatant of co-
cultures of dendritic cells and T cells from the atopic asthmatics
(n=8) with or without BCG, Dermatophagoides farinae (Df) extract
and supernatant of dendritic cells-BCG co-culture. Sup1, super-
natant of dendritic cells and BCG co-culture; Sup2, supernatant
of dendritic cells, BCG, and Df co-culture. 
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Fig. 4. Interleukin (IL)-5 concentration in the supernatant of den-
dritic cell and T cell co-cultures from the atopic asthmatics (n=8)
with or without BCG, Dermatophagoides farinae (Df) extract and
supernatant of dendritic cells-BCG co-culture. Sup1, supernatant
of dendritic cells and BCG co-culture; Sup2, supernatant of den-
dritic cells, BCG, and Df co-culture. 
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increased IL-5 production in DCs-T cell co-cultures (Fig. 4).
Both BCG and the culture supernatant from DCs+BCG+D.
farinae co-cultures significantly decreased IL-5 production.
However, the culture supernatants from DCs+BCG co-cul-
tures did not significantly decrease IL-5 production. Simi-
larly, D. farinae extract tended to increase IL-5 production
in the other study groups also, but neither BCG nor the cul-
ture supernatant showed a suppressive effect on IL-5 produc-
tion (Table 3). The IL-5 levels in the DCs-T+BCG co-cul-
ture supernatants tended to be lower in the atopic normal
(p=0.08) and atopic asthma (p=0.06) groups than in the non-
atopic normal group.
DISCUSSION
In this study, BCG infection of DCs and T cell co-cultures
increased IFN-γand decreased IL-5 production from T cells
in atopic asthmatics. These results are consistent with previ-
ous reports (2-7) that BCG has suppressive effects on asth-
ma. This study extended our previous report (18) showing
that the cytokine milieu secreted by BCG-treated DCs direct-
ly enhanced IFN-γproduction from T cells. The DCs+BCG
culture supernatant used in the previous study (18) did not
significantly suppress IL-5 production in the present study
too, but the DCs+BCG+D. farinae culture supernatant as
well as BCG did.
In addition, we found that BCG further increased IL-10
production from DCs in the presence of D. farinae extract.
This adjuvant effect of D. farinae extract was also observed
in increasing IFN-γproduction and in suppressing IL-5
production from T cells. These phenomena may be explain-
ed, at least in part, by more efficient polarization by simul-
taneous exposure of BCG and D. farinae to DCs. Shirota et
al. (15) demonstrated that low-dose CpG alone had no effect
on eosinophilia but had an efficient anti-allergic effect upon
co-inoculation with ovalbumin. Moreover, Kim et al. (14)
showed that the fusion of ovalbumin with IL-18 was more
efficient than a simple mixture of ovalbumin and IL-18 in
inducing IFN-γproduction. When DCs present allergens
to T cells, a ‘signal 3’ such as IL-12, which is induced through
TLRs by microbes (including BCG) and other factors, deter-
mines cell polarization (19). In this process, manipulation
by the same or neighboring DCs of both an allergen and
BCG administered together may more efficiently induce
the allergen-specific Th1 immune response (20). Although
the adjuvant effect of D. farinae extract on IFN-γproduc-
tion was associated with increase in IL-10 production, the
effect might be caused not by the inhibitory cytokine IL-10,
but by IL-2 and IFN-αthat are known to be related with
BCG-induced IFN-γproduction (21). And, the potent BCG
might induce maximal production of IL-12 without remain-
ing a space for increase by D. farinae extract. However, fur-
ther investigation is needed in these regards. 
In the present study, IL-10 and IL-12 productions from
DCs were increased in response to BCG, and the DCs+BCG+
D. farinae culture supernatant containing these cytokines
increased IFN-γand decreased IL-5 production from T cells.
De Wit et al. (13) showed that IL-5 production by T cells
from atopic individuals was not inhibited in the presence of
exogenous recombinant IL-12, the best-studied Th1-driving
factor (18). The timing of the allergen exposure to DCs might
be related to this discrepancy between the two studies. De
Wit et al. (13) cultured T cells with DCs pulsed beforehand
with D. pteronyssinus, in contrast to our DCs-T+D. farinae
co-culture. Although chronic antigen stimulation has been
found to render the T-cell (22) and DC (23) subsets more
resistant to change, reversals have been shown to occur in
animals (3, 5) and humans (7, 24). Thus, our results suggest
that simultaneous exposure of Th1 polarizing signal with
an allergen may suppress Th2 responses even in established
allergic diseases. 
In addition, the DCs+BCG±D. farinae culture super-
natants, i.e., a cytokine milieu containing IL-10 and IL-12,
were effective, but less so than BCG per se, in inducing Th1
polarization in atopic asthmatics in this study. BCG, but
not the DCs+BCG culture supernatant, induced T cell pro-
liferation over D. farinae alone did. Therefore, BCG-induced
T cell proliferation might be related, at least in part, to the
differential increase in Th1 polarizing activity over the cyto-
kine milieu-induced signal 3. For a productive immune
response, co-stimulatory signals (signal 2) as well as signal 3
induced by BCG must work together. 
Compared with non-atopic individuals, atopic subjects
produced more IL-10 from DCs and less IL-5 from T cells
Non-atopic
normal
(n=4)
Atopic
normal
(n=6)
Non-atopic
asthma
(n=5)
Atopic
asthma
(n=8)
IFN-γ (pg/mL)
DCs-T 6±61 ±00 ±00 ±0
DCs-T+Df 5±14 6 ±41 1±1* 7±4
DCs-T+BCG 714±229 485±345 112±102* 258±68
DCs-T+Df +BCG 826±232 816±307 135±93* 451±153
DCs-T+Df+Sup1 210±74 564±341 7±4* 147±83
DCs-T+Df+Sup2 334±144 638±345 26±11* 251±112
IL-5 (pg/mL)
DCs-T 4±20 ±03 ±33 ±3
DCs-T+Df 31±21 19±91 4 ±13 53±26
DCs-T+BCG 39±27 3±31 8 ±17 8±5
DCs-T+Df +BCG 56±47 31±18 21±20 36±20
DCs-T+Df+Sup1 28±16 37±22 9±64 9 ±28
DCs-T+Df+Sup2 25±19 42±25 2±13 7 ±20
Table 3. Comparisons of interferon (IFN)-γ and interleukin (IL)-5
concentrations in the dendritic cells (DCs) and T cells co-cul-
ture supernatants among study groups 
Df, Dermatophagoides farinae extract; BCG, Bacille Calmette-Guerin.
Sup1, culture supernatants of DCs+BCG; Sup2, culture supernatants of
DCs+BCG+Df; *p<0.05 compared to non-atopic normal.BCG-Induced DC Responses and IL-5 Suppression 633
in response to BCG in this study. T regulatory 1 (Tr1) cells,
which are induced by IL-10 (25), would produce high levels
of IL-10 and suppress IL-5 production (26). Th1 as well as
Th2 cells are suppressed by Tr1 cells, but the power of IL-
12 inducing Th1 cells may overcome the effect of Tr1 cells
resulting in an increase in IFN-γproduction from T cells.
In contrast to our results, Gentile et al. (27) demonstrated
that lipopolysaccharide-induced IL-10 production from DCs
was diminished in patients with asthma and allergic rhini-
tis, and suggested that atopic subjects may have an intrinsic
inability to up-regulate DC IL-10 production. Diminished
production of IL-12 also has been suggested as a risk factor
for atopy (28), as our result showing that the baseline IL-12
production from DCs was significantly lower in the atopic
asthma group than in the non-atopic normal. However, even
if atopic individuals are prone to develop allergic diseases
due to low levels of the baseline IL-10 and IL-12, the potent
Th1/Tr1 inducer BCG may overcome this barrier easily. BCG
efficiently and rather more remarkably increased production
of both IL-10 and IL-12 from DCs in the atopics than in the
non-atopics in this study. 
In the non-atopic asthmatics, BCG induced significantly
lower IL-10 production than in the atopic asthmatics and
lower IFN-γproduction than in non-atopic normal individ-
uals. Although it has been suggested that low IFN-γlevels
are a characteristic of asthma, regardless of the atopic state
(29), it should be determined whether BCG vaccination is
less effective in suppressing non-atopic asthma than atopic
asthma. Interestingly, the atopic normals did not show a high-
er production of IL-5 in response to D. farinae extract than
the non-atopics did. It remains to be determined whether
sensitized but not allergic subjects have any mechanism that
controls allergen-induced IL-5 production and eosinophilia.
This study has some limitations. First of all, the number of
study subjects was too small. Secondly, we are not sure that
the D. farinae extract was not contaminated with lipopolysac-
charide. The D. farinae extract augmented BCG-induced IL-
10 production from DCs even in the non-atopic individuals
in this study. In these regards, further studies are needed.
In conclusion, administration of BCG together with D.
farinae extract effectively decreased IL-5 production from T
cells, probably through the action of IL-10 and IL-12 released
from DCs in D. farinae-sensitive asthmatics. 
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